Novartis AG (BCBA:NVS)

Argentina flag Argentina · Delayed Price · Currency is ARS
37,975
+600 (1.61%)
At close: Jul 25, 2025, 5:00 PM BRT
1.61%
Market Cap293.56T
Revenue (ttm)65.77T
Net Income (ttm)16.27T
Shares Outn/a
EPS (ttm)8,163.07
PE Ratio18.04
Forward PE13.74
Dividend624.65 (1.65%)
Ex-Dividend DateMar 12, 2025
Volume65
Average Volume393
Open37,275
Previous Close37,375
Day's Range37,275 - 37,975
52-Week Range26,525 - 40,500
Betan/a
RSI56.57
Earnings DateJul 17, 2025

About Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 75,883
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol NVS
Full Company Profile

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.